HealthcareJul 26, 2026

ALEXION PHARMACEUTICALS, INC. (SYNTIMMUNE, INC.)

Company Profile Analysis

Book Demo Subscribe Now

ALEXION PHARMACEUTICALS, INC. (SYNTIMMUNE, INC.) - Healthcare showcase

Year Founded & Workforce

1991-12-31

3,000 Employees

Industry

Healthcare

Services

ALEXION PHARMACEUTICALS, INC. (SYNTIMMUNE, INC.) Overview

Company Headquarters: Massachusetts, US

Founded: 1992

Workforce: ~3,000

Company Working:

Alexion Pharmaceuticals, Inc. (Alexion) is a global biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies. The firm offers its products for a wide range of therapies including hematology, neurology, metabolic disorders, and among others. The company provides its well-known brands in the global market namely, Ultomiris, Soliris, Strensiq, and Kanuma. It has a direct and indirect presence in more than 50 countries including Switzerland, the US, UK, Japan, Mexico, Canada, etc. It offers its products to customers such as pharmacies, hospitals, hospital buying groups, and other healthcare providers. The company has a strong presence in Europe, North America, Latin America, and Asia-Pacific.

Strategy

Alexion Pharmaceuticals, Inc. focuses on offering its branded products across the globe. It focuses on the research and development in core therapeutic areas to launch innovative products in the market. Moreover, it focused on expands its rare disease business.

Company Snapshot

$3,649.5M

Revenue

3,000

Employees

1991-12-31

Founded

Massachusetts, US

Headquarters

SWOT Analysis

Strengths

Global presence
Highly skilled workforce

Weaknesses

Limited product portfolio

Opportunities

Opportunity to procure products by collaborations with governments

Threats

Changing competitive landscape

Key Developments

Date	Approach	Development
September 2018	Orphan Drug Designation	Syntimmune, Inc. (US), a subsidiary of Alexion that received FDA Orphan Drug Designation for its SYNT001 product.
September 2018	Acquisition	Alexion acquired Syntimmune, Inc. (US). This acquisition would help the company to add the orphan drugs portfolio.

Product Offering

ALEXION PHARMACEUTICALS, INC. (SYNTIMMUNE, INC.)
- Pemphigus

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles ALEXION PHARMACEUTICALS, INC. (SYNTIMMUNE, INC.) as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

ALEXION PHARMACEUTICALS, INC. (SYNTIMMUNE, INC.)

Company Headquarters: Massachusetts, US Founded: 1992 Workforce: ~3,000 Company Working: Alexion Pharmaceuticals, Inc. (Alexion) is a global biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies. The firm offers its products for a wide range of therapies including hematology, neurology, metabolic disorders, and among others. The company provides its well-known brands in the global market namely, Ultomiris, Soliris, Strensiq, and Kanuma. It has a direct and indirect presence in more than 50 countries including Switzerland, the US, UK, Japan, Mexico, Canada, etc. It offers its products to customers such as pharmacies, hospitals, hospital buying groups, and other healthcare providers. The company has a strong presence in Europe, North America, Latin America, and Asia-Pacific.

Starting from

$4,950